**Core Concept**
Apolipoprotein A-I (apoA-I) plays a crucial role in lipid metabolism by activating lecithin-cholesterol acyltransferase (LCAT), an enzyme responsible for converting cholesterol into cholesteryl esters. This process is vital for the formation of high-density lipoprotein (HDL), often referred to as "good" cholesterol.

**Why the Correct Answer is Right**
ApoA-I is the primary activator of LCAT, facilitating the transfer of a fatty acid from phosphatidylcholine to cholesterol, resulting in the formation of cholesteryl esters. This process is essential for the maturation of HDL particles and the subsequent removal of excess cholesterol from peripheral tissues to the liver for excretion. The activation of LCAT by apoA-I is a key step in maintaining cholesterol homeostasis and preventing atherosclerosis.

**Why Each Wrong Option is Incorrect**
**Option A:** B-48 is a component of chylomicrons, which are involved in the transport of dietary lipids from the intestine to the liver. While B-48 is an important apolipoprotein, it is not directly involved in the activation of LCAT.

**Option C:** A-II is another apolipoprotein found in HDL particles but does not possess the same ability to activate LCAT as apoA-I.

**Option D:** B-100 is a major component of low-density lipoprotein (LDL) particles, often referred to as "bad" cholesterol. While B-100 plays a critical role in lipid metabolism, it is not involved in the activation of LCAT.

**Clinical Pearl / High-Yield Fact**
ApoA-I and LCAT are key players in maintaining cholesterol homeostasis. Deficiencies in apoA-I, such as those seen in Tangier disease, can lead to severe hypercholesterolemia and premature atherosclerosis.

**✓ Correct Answer: B. A - I**